乳腺癌皮肤转移对卡培他滨的反应。 - Suppr

Suppr

超能文献

Response of cutaneous metastases from breast cancer to capecitabine.

作者信息

Sideras Kostandinos, Zahasky Katie M, Kaur Judith S

机构信息

Division of Medical Oncology, Mayo Clinic College of Medicine, Rochester, MN, U.S.A.

出版信息

Clin Med Oncol. 2008;2:415-8. doi: 10.4137/cmo.s521. Epub 2008 Apr 18.

DOI:10.4137/cmo.s521

PMID:21892308

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3161627/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1cf/3161627/7c882d314e93/cmo-2-2008-415f1.jpg

相似文献

Response of cutaneous metastases from breast cancer to capecitabine.

Clin Med Oncol. 2008;2:415-8. doi: 10.4137/cmo.s521. Epub 2008 Apr 18.

Capecitabine therapy of central nervous system metastases from breast cancer.

J Neurooncol. 2007 Nov;85(2):223-7. doi: 10.1007/s11060-007-9409-0. Epub 2007 Jul 5.

Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study.

Lancet Oncol. 2013 Jan;14(1):64-71. doi: 10.1016/S1470-2045(12)70432-1. Epub 2012 Nov 2.

Preferential inhibition of bone metastases by 5'-deoxy-5-fluorouridine and capecitabine in the 4T1/luc mouse breast cancer model.

Oncol Rep. 2005 Sep;14(3):695-9.

Concurrent capecitabine and whole-brain radiotherapy for treatment of brain metastases in breast cancer patients.

J Neurooncol. 2009 Jul;93(3):379-84. doi: 10.1007/s11060-008-9791-2. Epub 2009 Jan 25.

All-oral combination of lapatinib and capecitabine in patients with brain metastases from HER2-positive breast cancer--a phase II study.

J Egypt Natl Canc Inst. 2014 Dec;26(4):187-94. doi: 10.1016/j.jnci.2014.08.001. Epub 2014 Oct 5.

Capecitabine for 5-fluorouracil-resistant brain metastases from breast cancer.

Am J Clin Oncol. 2001 Aug;24(4):421-4. doi: 10.1097/00000421-200108000-00026.

Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma.

Cancer. 2006 Sep 15;107(6):1348-54. doi: 10.1002/cncr.22127.

Dramatic regression of multiple brain metastases from breast cancer with Capecitabine: another arrow at the bow?

Cancer Invest. 2006 Jun-Jul;24(4):466-8. doi: 10.1080/07357900600705805.

[A case of breast cancer liver metastases responding to lapatinib and capecitabine therapy].

Gan To Kagaku Ryoho. 2011 Nov;38(12):2180-2.

引用本文的文献

Phase 1/2 study of topical submicron particle paclitaxel for cutaneous metastases of breast cancer.

Breast Cancer Res Treat. 2022 Jul;194(1):57-64. doi: 10.1007/s10549-022-06584-6. Epub 2022 Apr 26.

Xeloda Oral, Trastuzumab, and Pertuzumab Combined Drug Therapy Reduced Cervical Lymphadenopathy and Dermal Involvement in Patient With Recurrent Breast Cancer: Case Report.

J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620942606. doi: 10.1177/2324709620942606.

Slowly progressive chest rash in an elderly woman.

JAAD Case Rep. 2018 Jan 12;4(2):111-113. doi: 10.1016/j.jdcr.2017.04.019. eCollection 2018 Mar.

Carcinoma en cuirasse as an initial manifestation of inflammatory breast cancer.

Postepy Dermatol Alergol. 2016 Apr;33(2):142-5. doi: 10.5114/pdia.2015.48069. Epub 2016 May 16.

Chemotherapy with low-dose capecitabine as palliative treatment in a patient with metastatic breast cancer: a case report.

Cases J. 2009 Nov 24;2:9081. doi: 10.1186/1757-1626-2-9081.

本文引用的文献

Results of chest wall resection for recurrent or locally advanced breast malignancies.

Breast. 2007 Jun;16(3):297-302. doi: 10.1016/j.breast.2006.12.008. Epub 2007 Feb 12.

Full-thickness chest wall resection for recurrent breast carcinoma: an institutional review and meta-analysis.

Am Surg. 2005 Sep;71(9):711-5.

Efficacy and safety of single agent capecitabine in pretreated metastatic breast cancer patients from the French compassionate use program.

Breast Cancer Res Treat. 2004 Nov;88(2):117-29. doi: 10.1007/s10549-004-1282-3.

Melanoma-like pigmented cutaneous metastases from breast carcinoma.

Clin Exp Dermatol. 2004 Mar;29(2):144-6. doi: 10.1111/j.1365-2230.2004.01458.x.

Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer.

Eur J Cancer. 2004 Mar;40(4):536-42. doi: 10.1016/j.ejca.2003.11.007.

[Re-irradiation after salvage mastectomy for local recurrence after a conservative treatment: a retrospective analysis of twenty patients (Nancy: 1988-2001)].

Cancer Radiother. 2003 Dec;7(6):369-79. doi: 10.1016/j.canrad.2003.07.001.

A phase II study of topical ceramides for cutaneous breast cancer.

Breast Cancer Res Treat. 2003 Jul;80(1):99-104. doi: 10.1023/A:1024409123726.

Multicenter phase II study of oral capecitabine (Xeloda(")) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy.

Ann Oncol. 2003 Aug;14(8):1227-33. doi: 10.1093/annonc/mdg346.

Cutaneous metastasis: a meta-analysis of data.

South Med J. 2003 Feb;96(2):164-7. doi: 10.1097/01.SMJ.0000053676.73249.E5.

Breast cancer recurrence after immediate reconstruction: patterns and significance.

Plast Reconstr Surg. 2003 Feb;111(2):712-20; discussion 721-2. doi: 10.1097/01.PRS.0000041441.42563.95.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验